Phase
Condition
Insomnia
Treatment
Mindfulness-based therapy for insomnia (MBTI)
Clinical Study ID
Ages 18-70 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
self-identified Black women
English speaking
meet ICSD3 diagnostic criteria for insomnia disorders, defined as difficultyinitiating or maintaining sleep that occurs despite adequate opportunity to sleepwith at least one associated daytime impairment symptom (ISI > 7)
additional quantitative insomnia criteria based on research recommendations and thenew ICSD3: (a) severity of sleep onset latency or wake time after sleep onset of ≥31min, (b) occurring ≥3 nights a week, and (c) for ≥ 3 months.
Exclusion
Exclusion Criteria:
Psychosis or unstable/significant depression, anxiety, or substance abuse underactive care (more than 1 monthly mental healthcare visit or requiring more than 1psychotropic medicine daily)
significant current practice of any form of meditation (>15min per day)
obstructive sleep apnea (OSA), restless legs syndrome (RLS), or circadian rhythmrelated condition (shift worker, use of medication that influence circadian rhythm,e.g., Parkinson's disease)
active or terminal cancer.
Study Design
Study Description
Connect with a study center
Yale School of Nursing Biobehavioral Lab
West Haven, Connecticut 06516
United StatesSite Not Available
Yale School of Nursing
New Haven 4839366, Connecticut 4831725 06477
United StatesActive - Recruiting
Yale School of Nursing Biobehavioral Lab
West Haven 4845419, Connecticut 4831725 06516
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.